• "Copy number alteration" as the sole molecular finding of a Thyroseq test is more commonly seen in Hurthle cell neoplasms
• A comparative analysis of treatment efficacy in intermediate-risk thyroid cancer
• A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications
• Case presentation of the smallest non-functional parathyroid carcinoma and review of the literature
• Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms
• Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1
• Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
• Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications
• Coexistence of Oncocytic (Hürthle cell) carcinoma with foci of anaplastic carcinoma and a metastasizing papillary carcinoma in one thyroid gland: Rare case report
• Ectopic thyroid in left parotid gland with an orthotopic thyroid gland: A rare case scenario
• Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma
• Exploring the Link between BMI and Aggressive Histopathological Subtypes in Differentiated Thyroid Carcinoma-Insights from a Multicentre Retrospective Study
• Forward Genetic Screens Identify Mechanisms of Resistance to Small-Molecule Lactate Dehydrogenase Inhibitors
• Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms
• Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
• High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases
• Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis
• Hurthle Cell Thyroid Carcinoma
• Hurthle Cell Thyroid Carcinoma
• Immunomorphological Patterns of Chaperone System Components in Rare Thyroid Tumors with Promise as Biomarkers for Differential Diagnosis and Providing Clues on Molecular Mechanisms of Carcinogenesis
• Impact of fine-needle aspiration cytology in thyroidectomy extent and associated surgical morbidity in thyroid cancer
• Lenvatinib as a Promising Treatment Option for Unresectable Hürthle Cell Carcinoma: A Case Report
• Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid
• Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update
• Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
• N-Nitrosomorpholine-induced oncocytic transformation in rat endocrine organs
• Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohort
• Oncocytic Change in Thyroid Pathology
• Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
• Oncocytic Poorly Differentiated Thyroid Carcinoma
• Outcomes and Trends of Treatments in High-Risk Differentiated Thyroid Cancer
• Parathyroid Cancer
• Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach
• Pituitary Metastases From Differentiated Thyroid Cancers: A Systematic Review
• Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy
• Radioactive Iodine for Thyroid Malignancies
• Radioactive Iodine for Thyroid Malignancies
• Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid
• Surgical management of spinal metastases from primary thyroid carcinoma: Demographics, clinical characteristics, and treatment outcomes - A retrospective analysis
• Synchronous Nasopharyngeal and Thyroid Malignancies: A Case Report
• Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
• The association between overweight/obesity and the risk of malignancy in Hurthle cell neoplasms of the thyroid
• The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms
• Thyroglobulin as a Rapid and Cost-Effective Biomarker for Diagnosis of Thyroid Carcinoma Brain Metastasis: A Case Report of a Patient with Metastatic Hurthle Cell Thyroid Carcinoma
• Thyroid Cancer
• Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms
• Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer
• Two synchronous paraneoplastic endocrine syndromes in a 53-year-old male with broadly metastatic widely invasive Hurthle cell carcinoma
• Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center